The murine nonclassical class I major histocompatibility complex-like CD1.1 molecule protects target cells from lymphokine-activated killer cell cytolysis
Cs. Chang et al., The murine nonclassical class I major histocompatibility complex-like CD1.1 molecule protects target cells from lymphokine-activated killer cell cytolysis, J EXP MED, 189(3), 1999, pp. 483-491
Classical class I major histocompatibility complex (MHC) molecules, as well
as the nonclassical class I histocompatibility leukocyte antigen (HLA)-E m
olecule, can negatively regulate natural killer (NK) cell cytotoxicity thro
ugh engagement of NK Inhibitory receptors. We show that expression of murin
e (m)CD1.1, a nonpolymorphic nonclassical MHC class I-like molecule encoded
outside the MHC, protects NK-sensitive RMA/S target cells from adherent ly
mphokine-activated killer cell (A-LAIC) cytotoxicity. Passage of effector c
ells in recombinant interleukin (rIL)-2 enhanced protection by mCD1.1, sugg
esting an expansion of relevant A-LAK population(s) or modulation of A-LAK
receptor expression. Murine CD1.1 conferred protection from lysis by rIL-2-
activated spleen cells of recombination activating gene (Rag)-1(-/-) mice,
which lack B and T cells, demonstrating that mCD1.1 can protect RMA/S cells
from lysis by NK cells. An antibody specific for mCD1.1 partially restored
A-LAK lysis of RMA/S.CD1.1 transfectants, indicating that cell surface mCD
1.1 can confer protection from lysis; therefore, mCD1.1 possibly acts throu
gh interaction with an NK inhibitory receptor. CD1.1 is by far the most div
ergent class I molecule capable of regulating NK cell activity. Finally, mC
D1.1 expression rendered RMA/S cells resistant to lysis by A-LAK of multipl
e mouse strains. The conserved structure of mCD1.1 and pattern of mCD1.1 re
sistance from A-LAK lysis suggest that mCD1.1 may be a ligand for a conserv
ed NK inhibitory receptor.